BPC-157 vs. TB-500: What's the Difference?
If you've spent any time reading about peptide therapy, you've seen these two names side by side: BPC-157 and TB-500. They're often discussed as a pair — sometimes nicknamed the "Wolverine stack" online — and they're among the most searched non-GLP-1 peptides in the country. But they're different compounds with different stories. Here's an honest breakdown.
What is BPC-157?
BPC-157 is a synthetic pentadecapeptide — a short chain of 15 amino acids. Its name comes from "Body Protection Compound," and it was originally identified in research related to gut tissue. In the research literature, it's the most-discussed peptide in the context of tissue recovery and gut-health studies, which is why it dominates the online conversation.
What is TB-500?
TB-500 is a synthetic fragment of thymosin beta-4, a protein that occurs naturally in the human body. Thymosin beta-4 plays roles in cell migration and tissue repair processes, and TB-500 represents the active fragment researchers study most. It's most often discussed in the context of recovery research — which is why it's constantly paired with BPC-157.
How they differ
BPC-157: a synthetic 15-amino-acid peptide. Research focus: tissue recovery, gut-health studies.
TB-500: a fragment of naturally occurring thymosin beta-4. Research focus: recovery research, cellular repair processes.
The practical difference for a patient: there isn't a simple "one is better" answer. They're studied in overlapping but distinct contexts, which is why clinicians interested in recovery protocols discuss them together rather than as substitutes.
The honest regulatory picture (read this part)
This is where most online content goes quiet, so let's be direct:
Neither compound is FDA-approved as a drug for any indication.
In July 2026, a federal advisory committee (PCAC) voted to recommend both for the FDA's 503A bulks list — the list of substances compounding pharmacies may use. That vote was non-binding, and the FDA has not started rulemaking. A recommendation is not an approval.
Much of what you see sold online as BPC-157 or TB-500 is marketed "for research use only" — not for human use, with no quality oversight. That market is unregulated, and product quality varies wildly.
A legitimate clinic can only offer these compounds through lawful channels with proper pharmacy sourcing and physician oversight. Anyone offering them casually — no medical screening, no prescription, no pharmacy you can name — is not operating at that standard.
If a provider can't explain the regulatory status above plainly, that's your answer about the provider.
What to ask any clinic before considering peptide therapy
Where do your compounds come from? (A licensed compounding pharmacy should be nameable.)
Who oversees my protocol? (A physician, with screening before anything is prescribed.)
What's the plan if something feels off? (There should be follow-up, not a checkout page.)
What are you not willing to offer? (A careful clinic has a "no" list. Ours includes investigational and restricted compounds.)
Where Ola stands
At Ola Big Island Wellness Clinic, peptide protocols are physician-supervised, sourced through licensed pharmacies, and built around your health history and goals — not around internet hype. BPC-157 and TB-500 are among the recovery-support compounds our physicians may discuss with qualifying patients, alongside options for sleep, vitality, and cellular energy.
Explore our peptide therapy programs (link: https://olabigisland.com/peptides) or book a free consultation (link: https://olabigisland.com/contact) — in person in Waimea or by telehealth anywhere in Hawaii. Call (808) 865-0762 (link: tel:+18088650762).
Medically reviewed by Dr. Crystal Broussard, MD — September 2026. This article is for informational purposes only and is not medical advice. Peptide therapy is not appropriate for everyone; consult a qualified physician.
